Development and Preclinical Evaluation of Virus Like Particle Vaccine Against COVID-19 Infection
Ismail C Yilmaz1,2*, Emre M Ipekoglu1*, Muzaffer Yildirim2*, Irem Evcili2*, Naz Yilmaz1, Artun Bulbul2, Nilsu Turay2, Yagmur Aydin1, Nese Guvencli1, Bilgi Gungor2, Berfu Saraydar2, Asli Gulce Bartan2, Bilgehan Ibibik2, Tugce Bildik2, İlayda Baydemir1, Sefa Burak Cam3, Eda Ciftci Dede3, Merve Gizer3, Osman Erganis4, Fahriye Sarac5, Serdar Uzar, Hakan Enul, Cumhur Adiay, Gamze Aykut2, Hivda Polat6, Saban Tekin6, Hasan E. Zeytin7, Petek Korkusuz3, Ihsan Gursel2#, Mayda Gursel1#
1Middle East Technical University, Department of Biological Sciences, Ankara, Turkey
2Bilkent University, Molecular Biology and Genetics Department, Ankara, Turkey
3Hacettepe University, Histology and Bioengineering Departments, Ankara, Turkey
4Selcuk University, Faculty of Veterinary Sciences, Konya, Turkey
5Pendik Veterinary Research and Control Institute, Istanbul, Turkey
6TUBITAK, Marmara Research Center, Istanbul, Turkey
7Nobel Pharma, Biotechnology Research Center, Istanbul, Turkey
*Ismail C Yilmaz, Emre M Ipekoglu, Muzaffer Yildirim, Irem Evcili should be considered joint first authors.
# Mayda Gursel and Ihsan Gursel should be considered joint senior authors.
#Corresponding Authors: M Gursel (mgursel@metu.edu.tr) and I Gursel (ihsangursel@bilkent.edu.tr)